PNC-27

PNC-27 5mg/vial by Deus Medical is an advanced research peptide developed to target and destroy cancer cells without harming healthy tissue. Engineered as a tumor-targeting peptide, PNC-27 binds to cancer cell membranes expressing HDM-2 proteins and induces rapid cell lysis, making it a promising agent in oncological research and experimental cancer therapy.

Each vial contains 5mg of lyophilized PNC-27, to be reconstituted with sterile or bacteriostatic water and administered via subcutaneous injection or as instructed by a research protocol. PNC-27 is not anabolic and does not interact with hormones, making it safe for use in non-performance contexts such as medical research, anti-cancer peptide therapy, and advanced healing studies.

Preliminary data suggest that PNC-27 may offer benefits in targeting tumor-specific cells, improving immune detection, and serving as a complementary treatment in experimental models alongside traditional cancer therapies. Though not yet approved for clinical use, its selectivity for cancer cells and non-toxicity to healthy cells have made it a subject of interest among scientists exploring non-invasive, targeted peptide therapies.

PNC-27 is for research purposes only and should be handled in controlled settings. Standard dosing in studies typically ranges between 50mcg to 500mcg per administration, depending on the model and protocol in use. It is not recommended for casual use or performance enhancement.

Now available at 7Steroids.com – your reliable source for research peptides and innovative bio-compounds with secure global shipping and discreet packaging.